Allel RET+3 : T a medullary thyroid cancer

Allel RET+3 : T a medullary thyroid cancer

Bibliographic Details
Main Authors:	Pławski A, Podralska M
Format:	Article
Language:	English
Published:	BMC 2011-06-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/9/S2/A12

Similar Items

RET mutations and medullary thyroid cancer
by: Chia-Chi Lin
Published: (2011-11-01)

Absence of the RET+3:T allele in the MTC patients
by: Borun Pawel, et al.
Published: (2012-10-01)

RET splice site variants in medullary thyroid carcinoma
by: Daryoush Saeed-Vafa, et al.
Published: (2024-03-01)

RET proto-oncogene mutations in the Slovenian population of patients with medullary thyroid cancer
by: Sara Milićević, et al.
Published: (2020-05-01)

RET mutations in a large indian family with medullary thyroid carcinoma
by: D M Mahesh, et al.
Published: (2014-01-01)

Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.
by: Lucieli Ceolin, et al.
Published: (2016-01-01)

A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01)

Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
by: Qin Huang, et al.
Published: (2020-05-01)

Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib
by: Carla Gambale, et al.
Published: (2024-01-01)

Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer
by: Leslie Cheng, et al.
Published: (2025-02-01)

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer
by: Tariq Alqahtani, et al.
Published: (2024-12-01)

RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation
by: Chia-Herng Yue, et al.
Published: (2021-06-01)

Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma
by: Larissa V. Bim, et al.
Published: (2019-07-01)

Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
by: Ségolène Hescot, et al.
Published: (2023-01-01)

Familial Medullary Thyroid Cancer: Five-year Review of the Most Frequent Mutations in the RET Gene: An Update
by: Blanca Estela Díaz Castañeda, et al.
Published: (2022-09-01)

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives
by: Ying Zhang, et al.
Published: (2024-09-01)

Point Mutations in RET Proto-Oncogene Exon 10 in Patients with Medullary Thyroid Carcinoma
by: Marjan Zarif-Yeganeh, et al.
Published: (2015-05-01)

Association between RET genotype and disease phenotype in patients with hereditary medullary thyroid carcinoma
by: ZHANG Gang, ZHANG Zhe, ZHANG Shu, LI Zhirong, TIAN Wuguo, HUANG Qi, WANG Lingli, XU Yan
Published: (2021-11-01)

Prophylactic thyroidectomy results among RET germline mutation bearers in families with hereditary forms of medullary thyroid cancer
by: Vladimir G. Polyakov, et al.
Published: (2016-05-01)

Somatic Mutations in Exons 10, 11, and 16 of the RET Protooncogene in Medullary Thyroid Carcinoma Patients
by: Elham Shakiba, et al.
Published: (2020-09-01)

A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation
by: Li-Lun Chuang, et al.
Published: (2016-11-01)

Design and Synthesis of Novel Thieno[3,2‑c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells
by: Gabriele La Monica, et al.
Published: (2023-09-01)

Real-world clinical profile, RET mutation testing, treatments and patient-related outcomes for medullary thyroid cancer in Europe
by: Grace Segall, et al.
Published: (2024-02-01)

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations
by: Özlem Boybeyi-Türer, et al.
Published: (2016-08-01)

CRISPR/Cas9 RET Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and Validation
by: Marjan Zarif-Yeganeh, et al.
Published: (2022-05-01)

Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
by: Sara Sheikholeslami, et al.
Published: (2014-02-01)

Higher <i>RET</i> Gene Expression Levels Do Not Represent anAlternative <i>RET</i> Activation Mechanism in Medullary Thyroid Carcinoma
by: Chiara Mulè, et al.
Published: (2021-10-01)

RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report
by: Vassos Neocleous, et al.
Published: (2023-06-01)

Participation of miRNA in conditioning the incidence and modification of the course of FAP
by: Pławski A, et al.
Published: (2011-06-01)

Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study
by: Mathiesen JS, et al.
Published: (2019-01-01)

Correction to “Design and Synthesis of Novel Thieno[3,2‑c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells”
by: Gabriele La Monica, et al.
Published: (2023-12-01)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
by: Ezra Y. Rosen, et al.
Published: (2022-03-01)

#5. Activating RET mutations in medullary thyroid cancer cells promotes osteoblastic bone metastasis by inhibiting osteoclastogenesis and stimulating osteoblast activity
by: Rozita Bagheri-Yarmand, et al.
Published: (2024-04-01)

Late-Onset Medullary Thyroid Cancer in a Patient with a Germline <i>RET</i> Codon C634R Mutation
by: Agnieszka Walczyk, et al.
Published: (2021-08-01)

Medullary thyroid cancer: epidemiology
by: S. Rybakov
Published: (2023-06-01)

Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study
by: Rachel Chava Rosenblum, et al.
Published: (2023-10-01)

RET kinase inhibitors for -altered thyroid cancers
by: Danica M. Vodopivec, et al.
Published: (2022-06-01)

Medullary Thyroid Cancer: Management Guidelines
by: F M Abdulkhabirova, et al.
Published: (2013-06-01)

Medullary Thyroid Cancer: Management Guidelines
by: F M Abdulkhabirova, et al.
Published: (2012-03-01)

Medullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two Patients
by: Rosa M. Paragliola, et al.
Published: (2018-07-01)